Parallel Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-393
| Closed | -$2.2K | – | 3658 |
|
|
2025
Q1 | $2.2K | Buy |
393
+75
| +24% | +$420 | ﹤0.01% | 2940 |
|
|
2024
Q4 | $2.15K | Buy |
318
+156
| +96% | +$1.06K | ﹤0.01% | 2924 |
|
|
2024
Q3 | $1.07K | Buy |
162
+160
| +8,000% | +$1.06K | ﹤0.01% | 3003 |
|
|
2024
Q2 | $15 | Hold |
2
| – | – | ﹤0.01% | 3277 |
|
|
2024
Q1 | $20 | Hold |
2
| – | – | ﹤0.01% | 3243 |
|
|
2023
Q4 | $20 | Sell |
2
-63
| -97% | -$630 | ﹤0.01% | 3266 |
|
|
2023
Q3 | $497 | Hold |
65
| – | – | ﹤0.01% | 3107 |
|
|
2023
Q2 | $486 | Buy |
+65
| New | +$486 | ﹤0.01% | 3107 |
|
|
2023
Q1 | – | Sell |
-29
| Closed | -$224 | – | 3496 |
|
|
2022
Q4 | $224 | Hold |
29
| – | – | ﹤0.01% | 3172 |
|
|
2022
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 3443 |
|
|
2022
Q2 | $0 | Buy |
+29
| New | – | ﹤0.01% | 3299 |
|
|
2022
Q1 | – | Sell |
-151
| Closed | -$3K | – | 3237 |
|
|
2021
Q4 | $3K | Sell |
151
-249
| -62% | -$4.95K | ﹤0.01% | 2602 |
|
|
2021
Q3 | $9K | Buy |
+400
| New | +$9K | ﹤0.01% | 2110 |
|